首页> 美国卫生研究院文献>Frontiers in Oncology >Laparoscopic and Robotic Total Mesorectal Excision in the Treatment of Rectal Cancer. Brief Review and Personal Remarks
【2h】

Laparoscopic and Robotic Total Mesorectal Excision in the Treatment of Rectal Cancer. Brief Review and Personal Remarks

机译:腹腔镜和机器人全直肠系膜切除术治疗直肠癌。简要评论和个人评论

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The current standard treatment for rectal cancer is based on a multimodality approach with preoperative radiochemotherapy in advanced cases and complete surgical removal through total mesorectal excision (TME). The most frequent surgical approach is traditional open surgery, as laparoscopic TME requires high technical skill, a long learning curve, and is not widespread, still being confined to centers with great experience in minimally invasive techniques. Nevertheless, in several studies, the laparoscopic approach, when compared to open surgery, has shown some better short-term clinical outcomes and at least comparable oncologic results. Robotic surgery for the treatment of rectal cancer is an emerging technique, which could overcome some of the technical difficulties posed by standard laparoscopy, but evidence from the literature regarding its oncologic safety and clinical outcomes is still lacking. This brief review analyses the current status of minimally invasive surgery for rectal cancer therapy, focusing on oncologic safety and the new robotic approach.
机译:当前直肠癌的标准治疗是基于多模式方法,对晚期病例进行术前放化疗,并通过全直肠系膜切除术(TME)完全手术切除。最常见的手术方法是传统的开放式手术,因为腹腔镜TME需要高技术技能,较长的学习曲线且不广泛,仍然局限于微创技术方面具有丰富经验的中心。尽管如此,在一些研究中,与开放手术相比,腹腔镜手术已显示出一些更好的短期临床疗效,至少在肿瘤学方面具有可比性。机器人外科手术治疗直肠癌是一项新兴技术,可以克服标准腹腔镜检查所带来的一些技术难题,但仍缺乏有关其肿瘤学安全性和临床结果的文献证据。本文简要分析了用于直肠癌治疗的微创手术的现状,重点是肿瘤安全性和新型机器人方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号